ViennaLab Diagnostics
PGX-HIV StripAssay®
HIV Therapy Pharmacogenomic Profiling
The PGX-HIV StripAssay® identifies allelic variants that play a large role in the success of Highly Active Retroviral Therapy (HAART), enabling tailored HIV treatment regimens for maximum effectiveness.
Key Features
01
HAART Allele Identification
Identifies allelic variants that significantly influence the success of Highly Active Retroviral Therapy (HAART).
02
Personalized HIV Treatment
Enables tailoring of HIV treatment regimens based on individual pharmacogenomic profiles.
03
Therapy Optimization
Supports selection of optimal antiretroviral drug combinations by identifying key pharmacogenomic markers.
04
PCR & Reverse Hybridization
Based on reverse hybridization of biotinylated PCR products for sensitive allele detection.
For Research Use Only (RUO)
PGX-HIV StripAssay® is intended for research use only in the United States and is not FDA-cleared for diagnostic use.